The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a <i>PIK3CA</i>-mutated endometrial cancer.

Front Oncol · 2022 · PMC9880853 · PMID 36713525

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

PIK3CA and PIK3R1 mutations were frequent and showed a strong trend for mutual exclusivity in all molecular subgroups, but they occurred with PTEN mutations in the MSI and copy-number low subgroups.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.